Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000424349 | SCV000512075 | likely benign | not provided | 2019-01-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19029688) |
Invitae | RCV003535703 | SCV000647499 | likely benign | Familial adenomatous polyposis 1 | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566135 | SCV000667262 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000566135 | SCV000681651 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-25 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000566135 | SCV002531860 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-17 | criteria provided, single submitter | curation | |
Ce |
RCV000424349 | SCV004159221 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | APC: BP4, BP7 |
Prevention |
RCV003897840 | SCV004717029 | likely benign | APC-related condition | 2021-01-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |